Emerging Trends in Drugs, Addictions, and Health International Society for the Study of Emerging Drugs (Issed)
Total Page:16
File Type:pdf, Size:1020Kb
EMERGING TRENDS IN DRUGS, ADDICTIONS, AND HEALTH INTERNATIONAL SOCIETY FOR THE STUDY OF EMERGING DRUGS (ISSED) AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Abstracting and Indexing p.1 • Editorial Board p.1 • Guide for Authors p.4 ISSN: 2667-1182 DESCRIPTION . Emerging Trends in Drugs, Addictions, and Health is a new international Journal devoted to the rapid publication of authoritative papers on Novel Psychoactive Substances (NPS), Addictions and associated health phenomena. The Journal has a multidisciplinary nature and aims to bring together studies which are relevant for heterogeneous authors and readers. Manuscripts related to pharmacology, clinical practice, doping science, mental health, public health, forensic medicine, experimental psychology, genetics, molecular biology, internal medicine, neuroscience, health psychology, health policy, health economics, and treatment trials are encouraged for submission as far as they deal with the ever changing world of addictions and psychoactive substances. The overall purpose of the Journal is to contribute to improve the knowledge on the field with a comprehensive biological, psychological, and social perspective. ABSTRACTING AND INDEXING . Directory of Open Access Journals (DOAJ) EDITORIAL BOARD . Editor-in-Chief Ornella Corazza, University of Hertfordshire Department of Clinical and Pharmaceutical Sciences, Hatfield, United Kingdom Addiction science, novel psychoactive substances, human enhance-ment drugs, mental health policy, body image, phenomenology, ethics Editorial Manager Andres Roman-Urrestarazu, University of Cambridge Department of Public Health and Primary Care, Cambridge, United Kingdom Novel psychoactive substances, autism, schizophrenia, adhd, psychia-try, drug policy Associate Editors Francesco Saverio Bersani, Sapienza University of Rome Department of Human Neurosciences, Roma, Italy Psychoneuroendocrinology, addiction science, aging, brain-modulation techniques, forensic psychiatry, mental health policy, neuropsychopharmacology Kim Kuypers, Maastricht University, Maastricht, Netherlands Neuropsychopharmacology, psychedelics, empathogens, social and stress hormones, placebo- controlled studies, mental well-being AUTHOR INFORMATION PACK 25 Sep 2021 www.elsevier.com/locate/etdah 1 Balasingam Kasinather Vicknasingam, Universiti Sains Malaysia Center for Drug Research, Minden, Malaysia Substance misuse, novel psychoactive substances, drug policy, HIV risk behaviors Editorial Board Fernando Barbosa, University of Porto Faculty of Psychology and Educational Sciences Laboratory of Neuropsychophysiology, Porto, Portugal Cognitive and affective neuroscience, neuropsychology neurophysiolo-gy, eeg/erp, antisocial behaviour, impulsive behaviour Giuseppe Bersani, University of Rome La Sapienza Department of Medical and Surgical Sciences and Biotechnologies, Latina, Italy Clinical psychiatry, psychopharmacology Francesco Botre, University of Lausanne, Lausanne, Switzerland Metabolomics, Anti-Doping, Pharmacokinetics, Toxicology Henrietta Bowden-Jones, University College London Department of Renal Medicine, London, United Kingdom Addictions, psychiatry Owen Bowden-Jones, Central and North West London NHS Foundation Trust, London, United Kingdom Emerging drug harms, novel psychoactive substance, club drugs Fabio Caputo, University of Ferrara Department of Neurosciences and Rehabilitation, Ferrara, Italy Katarzyna Czabanowska, Maastricht University Faculty of Health, Medicine and Life Sciences Graduate School Care and Public Health Research Institute Department of International Health, Maastricht, Netherlands Public health, public health workforce, health inequalities, public health leadership, competency based education and training, public health ethics Hironobu Fujiwara, Graduate School of Medicine Kyoto University Faculty of Medicine Department of Psychiatry, Kyoto, Japan Psychiatry, life science, behavioral addiction, sports medicine Claudio Imperatori, European University of Rome Department of Human Science Cognitive and Clinical Psychology Laboratory, Roma, Italy Psychopathology, substance-related and addictive disorders, food addiction, eating disorders, quantitative electroencephalography, neural networks, neuroimaging Barry Logan, Thomas Jefferson University College of Life Sciences, Philadelphia, Pennsylvania, United States of America Toxicology forensic science, novel psychoactive substances Gabriele Mandarelli, University of Bari Interdisciplinary Department of Medicine, Bari, Italy Forensic psychiatry, informed consent, decisionmaking capacity, mental health legislation Matteo Marti, University of Ferrara, Ferrara, Italy Pharmacology, Forensic Toxicology, Novel Psychoactive Substances, In vivo preclinical studies Giovanni Martinotti, Gabriele d'Annunzio University of Chieti and Pescara Department of Neuroscience and Imaging and Clinical Sciences, Chieti, Italy Neuroimaging, psychiatry, analytical philosophy, neuron, clinical psy-chology, psychopathology Eric Simón Murillo-Rodríguez, Anahuac Mayab University Division of Health Sciences, Merida, Mexico Neuroscience, cannabinoids and endocannabinoids, neurobiology of sleep Stefano Pallanti, Stanford University Department of Psychiatry and Behavioral Sciences, Palo Alto, California, United States of America Addiction science, psychiatry, therapies for neuropsychiatric disorders Olivier Rabin, World Anti-Doping Agency, Montréal, Quebec, Canada Anti-doping, pharmaceutical research Johannes Ramaekers, Maastricht University Faculty of Psychology and Neuroscience Department of Neuropsychology and Psychopharmacology, Maastricht, Netherlands Psychopharmacology, forensic toxicology, cognitive neuroscience Victor I. Reus, University of California San Francisco Weill Institute for Neurosciences, San Francisco, California, United States of America Mood disorders, bipolar disorder, psychopharmacology, psychoneuroendocri-nology, nicotine dependence and treatment Fabrizio Schifano, University of Hertfordshire Department of Clinical and Pharmaceutical Sciences, Hatfield, United Kingdom Novel psychoactive substance, substance misuse, psychiatry Justice Tettey, United Nations Office on Drugs and Crime, Wien, Austria Pharmacology, toxicology, novel psychoactive substance, drug policy Peter VanEenoo, Ghent University, Gent, Belgium Anti-doping Roberto Vicinanza, University of Southern California Leonard Davis School of Gerontology, Los Angeles, California, United States of America Nutrition, polypathology, mental health, aging Christopher Yates, Balearic Islands Health Research Institute (IdISBa), Illes Balears, Spain AUTHOR INFORMATION PACK 25 Sep 2021 www.elsevier.com/locate/etdah 2 Emergency Medicine, Medical Education, Healthcare Management, , Clinical Research, Clinical Toxicology, Recreational Drug Toxicity AUTHOR INFORMATION PACK 25 Sep 2021 www.elsevier.com/locate/etdah 3 GUIDE FOR AUTHORS . Your Paper Your Way We now differentiate between the requirements for new and revised submissions. You may choose to submit your manuscript as a single Word or PDF file to be used in the refereeing process. Only when your paper is at the revision stage, will you be requested to put your paper in to a 'correct format' for acceptance and provide the items required for the publication of your article. To find out more, please visit the Preparation section below. Submission checklist You can use this list to carry out a final check of your submission before you send it to the journal for review. Please check the relevant section in this Guide for Authors for more details. Ensure that the following items are present: One author has been designated as the corresponding author with contact details: • E-mail address • Full postal address All necessary files have been uploaded: Manuscript: • Include keywords • All figures (include relevant captions) • All tables (including titles, description, footnotes) • Ensure all figure and table citations in the text match the files provided • Indicate clearly if color should be used for any figures in print Graphical Abstracts / Highlights files (where applicable) Supplemental files (where applicable) Further considerations • Manuscript has been 'spell checked' and 'grammar checked' • All references mentioned in the Reference List are cited in the text, and vice versa • Permission has been obtained for use of copyrighted material from other sources (including the Internet) • A competing interests statement is provided, even if the authors have no competing interests to declare • Journal policies detailed in this guide have been reviewed • Referee suggestions and contact details provided, based on journal requirements For further information, visit our Support Center. BEFORE YOU BEGIN Ethics in publishing Please see our information on Ethics in publishing. Studies in humans and animals If the work involves the use of human subjects, the author should ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans. The manuscript should be in line with the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals and aim for the inclusion of representative human populations (sex, age and ethnicity) as per those recommendations. The terms sex and gender should be used correctly. Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy